A univariate survival analysis utilizing the GEO dataset revealed no survival difference between the mTOR high and low expression groups in GC patients who received surgery alone without adjuvant chemotherapy (GSE66229, 300 patients) (P=0.4536; Figure 3g). The gene discussed is MTOR; the disease is gastric cancer.